Disease progression in amyotrophic lateral sclerosis: Identifying the cost-utility of riluzole by disease stage

Manouchehr Tavakoli

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	156-165
Journal	The European Journal of Health Economics
Volume	3
Issue number	3
DOIs	https://doi.org/10.1007/s10198-002-0110-0
Publication status	Published - Sept 2002

Access to Document

@article{e5599d89caf2451b9fbfeaecfc3c2514,

title = "Disease progression in amyotrophic lateral sclerosis: Identifying the cost-utility of riluzole by disease stage",

author = "Manouchehr Tavakoli",

year = "2002",

month = sep,

doi = "10.1007/s10198-002-0110-0",

language = "English",

volume = "3",

pages = "156--165",

journal = "The European Journal of Health Economics",

issn = "1618-7598",

publisher = "Springer-Verlag",

number = "3",

}

TY - JOUR

T1 - Disease progression in amyotrophic lateral sclerosis: Identifying the cost-utility of riluzole by disease stage

AU - Tavakoli, Manouchehr

PY - 2002/9

Y1 - 2002/9

UR - http://www.scopus.com/inward/record.url?scp=0036970163&partnerID=8YFLogxK

U2 - 10.1007/s10198-002-0110-0

DO - 10.1007/s10198-002-0110-0

M3 - Article

SN - 1618-7598

VL - 3

SP - 156

EP - 165

JO - The European Journal of Health Economics

JF - The European Journal of Health Economics

IS - 3

ER -